<DOC>
	<DOCNO>NCT00332046</DOCNO>
	<brief_summary>Evidence suggest use neuroimaging detect therapeutic effect anxiolytic treatment appropriate cognitive-emotional task use activate emotional brain neurocircuitry believe involve core symptom disease .</brief_summary>
	<brief_title>fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : Primary diagnosis Social Anxiety Disorder . Willing restrict alcohol limit intake . Exclusion criterion : History schizophrenia , schizoaffective disorder bipolar disorder . Lefthanded . Suffer claustrophobia . Any reason subject could go fMRI , example metal implant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>fMRI placebo GW679769 Social Anxiety Disorder SAD</keyword>
</DOC>